{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"13.66","value":"-3.3"},{"groupId":"OG001","spread":"13.48","value":"-2.7"}]}],"title":"SBP, Week 1, n=231, 443"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"13.75","value":"-5.0"},{"groupId":"OG001","spread":"14.05","value":"-3.2"}]}],"title":"SBP, Week 2, n=227, 437"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"13.61","value":"-6.1"},{"groupId":"OG001","spread":"13.63","value":"-3.7"}]}],"title":"SBP, Week 4, n=218, 429"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"14.00","value":"-4.3"},{"groupId":"OG001","spread":"13.86","value":"-3.9"}]}],"title":"SBP, Week 6, n=196, 420"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"14.04","value":"-3.6"},{"groupId":"OG001","spread":"14.15","value":"-3.9"}]}],"title":"SBP, Week 8, n=190, 416"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"13.17","value":"-4.0"},{"groupId":"OG001","spread":"14.07","value":"-3.6"}]}],"title":"SBP, Week 12, n=165, 405"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"13.69","value":"-4.2"},{"groupId":"OG001","spread":"13.88","value":"-3.8"}]}],"title":"SBP, Week 16, n=140, 376"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"15.09","value":"-4.1"},{"groupId":"OG001","spread":"14.84","value":"-3.2"}]}],"title":"SBP, Week 20, n=135, 363"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"15.88","value":"-3.7"},{"groupId":"OG001","spread":"15.88","value":"-2.9"}]}],"title":"SBP, Week 24, n=88, 249"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"12.79","value":"-3.0"},{"groupId":"OG001","spread":"16.62","value":"-3.3"}]}],"title":"SBP, Week 28, n=74, 202"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"11.95","value":"-3.1"},{"groupId":"OG001","spread":"16.12","value":"-2.6"}]}],"title":"SBP, Week 32, n=68, 183"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"13.73","value":"-2.4"},{"groupId":"OG001","spread":"16.43","value":"-3.0"}]}],"title":"SBP, Week 36, n=68, 175"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"11.95","value":"-2.7"},{"groupId":"OG001","spread":"16.47","value":"-3.4"}]}],"title":"SBP, Week 40, n=64, 169"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"12.98","value":"-2.5"},{"groupId":"OG001","spread":"16.76","value":"-3.8"}]}],"title":"SBP, Week 44, n=64, 166"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"14.94","value":"-3.8"},{"groupId":"OG001","spread":"15.65","value":"-3.1"}]}],"title":"SBP, End of Treatment, n=213, 420"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"13.95","value":"-0.7"},{"groupId":"OG001","spread":"16.23","value":"-1.2"}]}],"title":"SBP, 4-week FU, n=204, 402"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"14.24","value":"-0.4"},{"groupId":"OG001","spread":"15.68","value":"-0.7"}]}],"title":"SBP, 12-week FU, n=198, 401"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"14.04","value":"-0.1"},{"groupId":"OG001","spread":"16.02","value":"0.1"}]}],"title":"SBP, 24-week FU, n=197, 394"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"9.57","value":"-1.3"},{"groupId":"OG001","spread":"9.21","value":"-1.5"}]}],"title":"DBP, Week 1, n=231, 443"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.05","value":"-2.6"},{"groupId":"OG001","spread":"9.11","value":"-1.8"}]}],"title":"DBP, Week 2, n=227, 437"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.01","value":"-3.2"},{"groupId":"OG001","spread":"10.12","value":"-2.3"}]}],"title":"DBP, Week 4, n=218, 429"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"9.13","value":"-1.9"},{"groupId":"OG001","spread":"9.69","value":"-3.1"}]}],"title":"DBP, Week 6, n=196, 420"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"9.67","value":"-2.7"},{"groupId":"OG001","spread":"10.03","value":"-2.6"}]}],"title":"DBP, Week 8, n=190, 416"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"9.92","value":"-3.0"},{"groupId":"OG001","spread":"10.05","value":"-2.8"}]}],"title":"DBP, Week 12, n=165, 405"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"9.19","value":"-2.4"},{"groupId":"OG001","spread":"10.01","value":"-3.1"}]}],"title":"DBP, Week 16, n=140, 376"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.04","value":"-3.5"},{"groupId":"OG001","spread":"9.59","value":"-2.4"}]}],"title":"DBP, Week 20, n=135, 363"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.60","value":"-2.4"},{"groupId":"OG001","spread":"9.95","value":"-2.9"}]}],"title":"DBP, Week 24, n=88, 249"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.32","value":"-3.7"},{"groupId":"OG001","spread":"10.43","value":"-3.0"}]}],"title":"DBP, Week 28, n=74, 202"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.93","value":"-1.7"},{"groupId":"OG001","spread":"9.99","value":"-2.5"}]}],"title":"DBP, Week 32, n=68, 183"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"11.51","value":"-1.5"},{"groupId":"OG001","spread":"9.84","value":"-3.1"}]}],"title":"DBP, Week 36, n=68, 175"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.65","value":"-2.7"},{"groupId":"OG001","spread":"10.99","value":"-2.9"}]}],"title":"DBP, Week 40, n=64, 169"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.96","value":"-2.8"},{"groupId":"OG001","spread":"10.54","value":"-3.2"}]}],"title":"DBP, Week 44, n=64, 166"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.07","value":"-2.8"},{"groupId":"OG001","spread":"10.26","value":"-2.8"}]}],"title":"DBP, End of Treatment, n=213, 420"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"9.30","value":"-1.8"},{"groupId":"OG001","spread":"10.67","value":"-1.2"}]}],"title":"DBP, 4-week FU, n=204, 402"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.48","value":"-1.4"},{"groupId":"OG001","spread":"10.09","value":"-0.9"}]}],"title":"DBP, 12-week FU, n=198, 401"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"9.90","value":"-0.6"},{"groupId":"OG001","spread":"9.97","value":"-0.3"}]}],"title":"DBP, 24-week FU, n=197, 394"}],"denoms":[{"counts":[{"groupId":"OG000","value":"231"},{"groupId":"OG001","value":"444"}],"units":"Participants"}],"description":"Participant's blood pressure was measured at the indicated time points during the study. Systolic blood pressure is a measure of blood pressure while the heart is beating. Diastolic blood pressure is a measure of blood pressure while the heart is relaxed. Mean change from Baseline was calculated as the value at the indicated time points minus the value at Baseline.","dispersionType":"Standard Deviation","groups":[{"description":"Participants completing the OL Phase were administered matching placebo tablets QD in combination with antiviral therapy (peginterferon alfa-2a and ribavirin) for a duration of either 24 or 48 weeks (for participants with Genotype 2/3) or 48 weeks (for participants with Non-Genotype 2/3).","id":"OG000","title":"Placebo+Antiviral Therapy: DB Phase"},{"description":"Participants completing the OL Phase continued on the same dose of eltrombopag received in the OL Phase (dose that effectively raised platelets to \\>=90 Gi/L) in combination with antiviral therapy (peginterferon alfa-2a and ribavirin) for a duration of either 24 or 48 weeks (for participants with Genotype 2/3) or 48 weeks (for participants with Non-Genotype 2/3).","id":"OG001","title":"Eltrombopag+Antiviral Therapy: DB Phase"}],"paramType":"MEAN","populationDescription":"Safety DB Population. Only those participants contributing data at the indicated time points were analyzed.","reportingStatus":"POSTED","timeFrame":"DB Phase: Baseline; Weeks 1, 2, 4, 6, 8, 12, 16, 20, 24, 28, 32, 36, 40, and 44; End of Treatment (up to Week 48); 4-week Follow-up (FU) (up to Week 52); 12-week FU (up to Week 60); and 24-week FU (up to Week 72)","title":"Mean Change From Baseline in Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) at the Indicated Time Points During the DB Phase","type":"SECONDARY","unitOfMeasure":"Millimeters of mercury (mmHg)"}